Inventaire - dine venner og fællesskaber er dit bedste bibliotek

Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer

forfatter

Celine M. Vachon

Karla Kerlikowske

Diana Miglioretti

Jeffrey A Tice

Charlotte C Gard

udgivet i: Journal of Clinical Oncology

dato for udgivelse: 2015-08-17

sprog: engelsk

main subject: breast disease, brystkræft

Cites articles 32

Date

Titel

Forfattere

2015-03-04

The contributions of breast density and common genetic variation to breast cancer risk

Douglas Easton, Fergus J. Couch, Peter A. Fasching, Matthias W. Beckmann, Julie M. Cunningham, Celine M. Vachon, Janet E. Olson, Karla Kerlikowske
2015-01-26

Model for individualized prediction of breast cancer risk after a benign breast biopsy

Celine M. Vachon, Derek C Radisky, Amy C Degnim, Daniel W Visscher, Robert Vierkant, Tina J Hieken, Marlene H Frost, Lynn C. Hartmann
2015

Cancer statistics, 2015
2014-10-08

Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I.

Adam R Brentnall, Jane Warwick, Jennifer Stone, Anthony Howell, Jack Cuzick
2014-07-01

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Neil J Stone, Daniel Levy, Alice H. Lichtenstein, Donald Lloyd-Jones
2014-12-03

Breast cancer chemoprevention: the saga of underuse continues
2013-11-01

Medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force recommendation statement.

Michael P. Pignone, United States Preventive Services Task Force, Virginia A. Moyer
2013-07-08

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline

Maria C. Katapodi, Monica Morrow, Barbara A Parker, Judy E. Garber, Scott Lippman
2013-06-06

Benign breast disease, mammographic breast density, and the risk of breast cancer

Rachel Ballard-Barbash, Celine M. Vachon, Karla Kerlikowske, Donald L. Weaver
2010-11-05

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

Michael J Pencina, Ewout W. Steyerberg
2010-07-06

Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia

Robert Vierkant, Amy C Degnim, Judy Boughey, Marlene H Frost, Lynn C. Hartmann
2009-06-01

Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures

Paul Ridker, Nancy R. Cook
2009-03-01

How to evaluate the calibration of a disease risk prediction tool

Françoise Clavel-Chapelon
2009-08-25

The effects of a FRAX revision for the USA.

L. Joseph Melton
2009-01-01

Where's the outrage?
2008-10-14

Assessment of the accuracy of the Gail model in women with atypical hyperplasia

Celine M. Vachon, Amy C Degnim, Judy Boughey, Marlene H Frost, Lynn C. Hartmann
2008-03-01

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model

Rebecca Smith-Bindman, Karla Kerlikowske
2008-02-12

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

Ramachandran S. Vasan, Michael J Pencina, Joseph M Massaro
2008-01-30

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Ramachandran S. Vasan, Michael J Pencina
2006-06-21

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial,Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

Reena Cecchini, Steven E. Reis, V. Craig Jordan, Patricia Ganz
2006-09-01

Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density.

Celia Byrne, Barry I. Graubard
2005-06-01

Partly conditional survival models for longitudinal data
2005-06-01

Performance benchmarks for diagnostic mammography

Rachel Ballard-Barbash, Rebecca Smith-Bindman, Diana Miglioretti, Berta M. Geller, Bonnie C. Yankaskas, Edward A Sickles
2004-04-01

A breast cancer prediction model incorporating familial and personal risk factors.

Jack Cuzick
2003-11-01

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme

Gareth Evans, Eitan Amir
2003-01-11

Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study

William D. Dupont
2000-06-01

Time-dependent ROC curves for censored survival data and a diagnostic marker
1998-09-16

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1997-10-01

Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database

Karla Kerlikowske, Berta M. Geller, Bonnie C. Yankaskas, Patricia A Carney
1989-12-01

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

Louise A. Brinton
1985-01-01

Risk factors for breast cancer in women with proliferative breast disease
1985-06-01

Atypical hyperplastic lesions of the female breast. A long-term follow-up study

Artikel - wd:Q36090967

Welcome to Inventaire

dit venne- og fællesskabs bibliotek

vil du vide mere